XML 17 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (4,214,875) $ (8,545,885)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on impairment of goodwill 8,134,000 10,918,000
Amortization of debt discounts 4,966
Depreciation and amortization 5,398 4,748
Change in fair value of subscription agreement liability – related party (3,319,000)
Net periodic pension benefit (89,827)
Stock-based compensation 22,305 29,256
Gain on forgiveness of accounts payable (944,694)
Change in fair value of contingent warrant liability (1,612) 9,795
Change in fair value of Series D derivative liability (3,955,778)
Change in fair value of Series E derivative liability (2,072,590)
Disposal of property and equipment 2,472
Changes in operating assets and liabilities:    
Accounts receivable 270,735 9,453
Inventories 11,654 (91,019)
Investor receivable 50,000
Prepaid expenses and other current assets (83,396) 3,638
Accounts payable (224,779) (261,362)
Accrued expenses (62,543) 269,779
Net cash used in operating activities (2,121,481) (1,999,680)
Cash flows from investing activities    
Net cash Provided by (used in) investing activities
Cash flows from financing activities    
Proceeds from issuance of note payable 247,196 100,000
Principal payments of notes payable (937,550)
Payment for redemption of Series C Preferred Stock (1,318,813)
Proceeds from exercise of warrants 384,842
Cash in lieu of shares (250)
Proceeds from issuance of common stock in connection with the ELOC 5,026,617
Net cash provided by financing activities 631,788 2,870,254
Effect of exchange rate changes on cash (14,889) 60,119
Net increase (decrease) in cash (1,504,582) 930,693
Cash, beginning of period 5,220,654 646,500
Cash, end of period 3,716,072 1,577,193
Supplemental disclosure of cash flow information:    
Cash paid for interest 21,162
Noncash investing and financing activities:    
D&O insurance premium financed 460,875
Conversion of Series D preferred stock to common stock 22
Conversion of Series E preferred stock to common stock 1
Deemed dividend owed to Series C preferred stock shareholders $ 394,757